Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Dexamethasone Inner Ear Perfusion by Intratympanic Injection in Unilateral Ménière's Disease: A Two‐year Prospective, Placebo‐Controlled, Double‐blind, Randomized Trial

Garduño‐Anaya, Marco Antonio, De Toledo, Heloísa Couthino, Hinojosa‐González, Ramón, Pane‐Pianese, Carlo, Ríos‐Castañeda, Luis Camilo·2005·Otolaryngology–Head and Neck Surgery

Abstract

Objective: To investigate the efficacy of dexamethasone inner ear perfusion by intratympanic injection in hearing loss, tinnitus, aural fullness, and vertigo in the treatment of unilateral Ménière's disease and compare it with the control group. Study Design and Setting: A prospective, randomized, double‐blind study with 2‐year follow‐up comparing changes secondary to dexamethasone inner ear perfusion versus placebo consisting of saline solution. Patients: Twenty‐two patients having definite Ménière's disease as outlined by the 1995 American Academy of Otolaryngology‐Head and Neck Surgery Committee on Hearing and Equilibrium. All the patients were older than 18 years of age and were not receiving any other form of treatment with steroids for their Ménière's disease. Method: Five consecutive daily intratympanic injections of dexamethasone or placebo to the involved ear. Results: In the dexamethasone group at 2‐year follow‐up, complete control of vertigo (class A) was achieved in 9 of 11 patients (82%) and substantial control of vertigo (class B) in the remaining 2 patients (18%.) In the control group only 7 of 11 patients (64%) finished the 2‐year follow‐up because in the other 4 patients (36%) we had to give another treatment for the continuing vertigo and thus they were classified as failure (class F.) From the 7 patients who have finished the follow‐up of 2 years in the control group, 4 patients (57%) achieved class A, 2 patients (29%) achieved class C, and 1 patient (14%) class F. Conclusions: Dexamethasone (4 mg/mL) inner ear perfusion in a group of patients with unilateral Ménière's disease (Shea's stage III) showed 82% of complete control of vertigo over placebo (57%). There was also a subjective improvement in tinnitus (48%), hearing loss (35%), and aural fullness (48%) in the dexamethasone group compared with 20%, 10%, and 20% respectively in the control group. EBM Rating: A

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.otohns.2005.05.010

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 217

Metadata

Authors
Garduño‐Anaya, M. A., De Toledo, H. C., Hinojosa‐González, R., Pane‐Pianese, C., & Ríos‐Castañeda, L. C.
Venue
Otolaryngology–Head and Neck Surgery
Publisher
Wiley
Published
2005-08
Volume
133
Issue
2
Pages
285-294
ISSN
  • 0161-6439 (ISSN-L)
  • 0194-5998
  • 1097-6817
OpenAlex
W2110001084
Cited by
217
References
1
FWCI
2.86
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dexamethasone Inner Ear Perfusion by Intratympanic Injection in Unilateral Ménière's Disease: A Two‐year Prospective, Placebo‐Controlled, Double‐blind, Randomized Trial. https://app.cochat.ai/papers/10.1016/j.otohns.2005.05.010
The paper
Garduño‐Anaya, M. A., De Toledo, H. C., Hinojosa‐González, R., Pane‐Pianese, C., & Ríos‐Castañeda, L. C. (2005). Dexamethasone Inner Ear Perfusion by Intratympanic Injection in Unilateral Ménière's Disease: A Two‐year Prospective, Placebo‐Controlled, Double‐blind, Randomized Trial. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1016/j.otohns.2005.05.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.